Annual Short Term Debt
$1.29 M
$0.000.00%
December 31, 2023
Summary
- As of February 7, 2025, LXRX annual short term debt is $1.29 million, unchanged on December 31, 2023.
- During the last 3 years, LXRX annual short term debt has fallen by -$10.91 million (-89.42%).
- LXRX annual short term debt is now -96.65% below its all-time high of $38.48 million, reached on December 31, 2009.
Performance
LXRX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$1.30 M
+$10.00 K+0.77%
September 30, 2024
Summary
- As of February 7, 2025, LXRX quarterly short term debt is $1.30 million, with the most recent change of +$10.00 thousand (+0.77%) on September 30, 2024.
- Over the past year, LXRX quarterly short term debt has increased by +$10.00 thousand (+0.77%).
- LXRX quarterly short term debt is now -96.65% below its all-time high of $38.86 million, reached on September 30, 2009.
Performance
LXRX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
LXRX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | +0.8% |
| 3 y3 years | -89.4% | -7.5% |
| 5 y5 years | +15.8% | -88.5% |
LXRX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.6% | -7.5% | +64.9% |
| 5 y | 5-year | -89.4% | +18.6% | -89.8% | +64.9% |
| alltime | all time | -96.7% | +58.2% | -96.7% | +96.2% |
Lexicon Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.30 M(+0.8%) |
| Jun 2024 | - | $1.29 M(0.0%) |
| Mar 2024 | - | $1.29 M(0.0%) |
| Dec 2023 | $1.29 M(0.0%) | $1.29 M(0.0%) |
| Sep 2023 | - | $1.29 M(0.0%) |
| Jun 2023 | - | $1.29 M(0.0%) |
| Mar 2023 | - | $1.29 M(0.0%) |
| Dec 2022 | $1.29 M(+18.5%) | $1.29 M(-8.2%) |
| Sep 2022 | - | $1.41 M(+78.2%) |
| Jun 2022 | - | $789.00 K(-16.1%) |
| Mar 2022 | - | $940.00 K(-13.7%) |
| Dec 2021 | $1.09 M(-91.1%) | $1.09 M(-91.4%) |
| Sep 2021 | - | $12.72 M(+0.1%) |
| Jun 2021 | - | $12.70 M(+0.1%) |
| Mar 2021 | - | $12.69 M(+4.0%) |
| Dec 2020 | $12.20 M(+5.5%) | $12.20 M(+32.0%) |
| Sep 2020 | - | $9.24 M(-16.0%) |
| Jun 2020 | - | $11.01 M(+2.6%) |
| Mar 2020 | - | $10.73 M(-7.2%) |
| Dec 2019 | $11.56 M(+937.2%) | $11.56 M(+2.4%) |
| Sep 2019 | - | $11.29 M(+912.5%) |
| Jun 2019 | - | $1.11 M(0.0%) |
| Mar 2019 | - | $1.11 M(0.0%) |
| Dec 2018 | $1.11 M(-92.1%) | $1.11 M(0.0%) |
| Sep 2018 | - | $1.11 M(-91.4%) |
| Jun 2018 | - | $12.90 M(-4.6%) |
| Mar 2018 | - | $13.52 M(-4.1%) |
| Dec 2017 | $14.09 M(-13.4%) | $14.09 M(-3.7%) |
| Sep 2017 | - | $14.63 M(-3.5%) |
| Jun 2017 | - | $15.16 M(-3.8%) |
| Mar 2017 | - | $15.75 M(-3.2%) |
| Dec 2016 | $16.28 M(+723.9%) | $16.28 M(-3.0%) |
| Sep 2016 | - | $16.79 M(-2.9%) |
| Jun 2016 | - | $17.29 M(+755.9%) |
| Mar 2016 | - | $2.02 M(+2.2%) |
| Dec 2015 | $1.98 M(-90.2%) | $1.98 M(-89.5%) |
| Sep 2015 | - | $18.79 M(-2.4%) |
| Jun 2015 | - | $19.25 M(-2.3%) |
| Mar 2015 | - | $19.71 M(-2.3%) |
| Dec 2014 | $20.17 M(+1079.4%) | $20.17 M(-2.1%) |
| Sep 2014 | - | $20.61 M(+1055.9%) |
| Jun 2014 | - | $1.78 M(+2.1%) |
| Mar 2014 | - | $1.75 M(+2.1%) |
| Dec 2013 | $1.71 M | $1.71 M(+2.1%) |
| Sep 2013 | - | $1.68 M(-92.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $22.68 M(+1311.2%) |
| Mar 2013 | - | $1.61 M(+2.1%) |
| Dec 2012 | $1.57 M(+9.1%) | $1.57 M(+2.1%) |
| Sep 2012 | - | $1.54 M(+2.1%) |
| Jun 2012 | - | $1.51 M(+2.2%) |
| Mar 2012 | - | $1.48 M(+2.4%) |
| Dec 2011 | $1.44 M(+26.8%) | $1.44 M(+2.1%) |
| Sep 2011 | - | $1.41 M(+2.4%) |
| Jun 2011 | - | $1.38 M(+19.5%) |
| Mar 2011 | - | $1.16 M(+1.5%) |
| Dec 2010 | $1.14 M(-97.0%) | $1.14 M(+2.2%) |
| Sep 2010 | - | $1.11 M(-93.5%) |
| Jun 2010 | - | $17.10 M(-53.3%) |
| Mar 2010 | - | $36.60 M(-4.9%) |
| Dec 2009 | $38.48 M(+3896.1%) | $38.48 M(-1.0%) |
| Sep 2009 | - | $38.86 M(+3770.5%) |
| Jun 2009 | - | $1.00 M(+2.0%) |
| Mar 2009 | - | $984.00 K(+2.2%) |
| Dec 2008 | $963.00 K(+9.4%) | $963.00 K(+2.0%) |
| Sep 2008 | - | $944.00 K(+2.2%) |
| Jun 2008 | - | $924.00 K(+2.1%) |
| Mar 2008 | - | $905.00 K(+2.8%) |
| Dec 2007 | $880.00 K(+7.8%) | $880.00 K(+2.2%) |
| Sep 2007 | - | $861.00 K(+2.0%) |
| Jun 2007 | - | $844.00 K(+2.2%) |
| Mar 2007 | - | $826.00 K(+1.2%) |
| Dec 2006 | $816.00 K(-82.8%) | $816.00 K(-83.0%) |
| Sep 2006 | - | $4.80 M(+0.4%) |
| Jun 2006 | - | $4.78 M(+0.3%) |
| Mar 2006 | - | $4.77 M(+0.3%) |
| Dec 2005 | $4.75 M(+1.3%) | $4.75 M(+0.3%) |
| Sep 2005 | - | $4.74 M(+0.3%) |
| Jun 2005 | - | $4.72 M(+0.3%) |
| Mar 2005 | - | $4.71 M(+0.3%) |
| Dec 2004 | $4.69 M(+363.5%) | $4.69 M(+592.9%) |
| Sep 2004 | - | $677.00 K(+2.1%) |
| Jun 2004 | - | $663.00 K(-94.1%) |
| Sep 2001 | - | $11.18 M(+1047.7%) |
| Jun 2001 | - | $974.40 K(-5.4%) |
| Mar 2001 | - | $1.03 M(+1.8%) |
| Dec 2000 | $1.01 M(-15.7%) | $1.01 M(+15.8%) |
| Sep 2000 | - | $874.10 K(-3.0%) |
| Jun 2000 | - | $901.30 K(-22.1%) |
| Mar 2000 | - | $1.16 M |
| Dec 1999 | $1.20 M | - |
FAQ
- What is Lexicon Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual short term debt year-on-year change?
- What is Lexicon Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly short term debt year-on-year change?
What is Lexicon Pharmaceuticals annual short term debt?
The current annual short term debt of LXRX is $1.29 M
What is the all time high annual short term debt for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual short term debt is $38.48 M
What is Lexicon Pharmaceuticals annual short term debt year-on-year change?
Over the past year, LXRX annual short term debt has changed by $0.00 (0.00%)
What is Lexicon Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of LXRX is $1.30 M
What is the all time high quarterly short term debt for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly short term debt is $38.86 M
What is Lexicon Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, LXRX quarterly short term debt has changed by +$10.00 K (+0.77%)